BMY — Bristol-Myers Squibb Co Share News
0.000.00%
Last trade - 00:00- $110.27bn
- $144.28bn
- $48.19bn
Brief: Bristol Myers Squibb Announces Dividend
Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trial
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Izalontamab Brengitecan Shows Significant OS And PFS Improvements In TNBC And ESCC
Brief: Bristol Myers Squibb Announces Opdivo® (Nivolumab) In Combination With Avd Receives Expanded EU Label With Approval In Frontline Advanced Classical Hodgkin Lymphoma
Brief: U.S. FDA Accepts for Priority Review Bristol Myers Squibb’s Supplemental New Drug Application for Camzyos (mavacamten)
Incyte blood cancer drug combo reduces disease-progression risk but with high side-effect rate
Replimune soars on plans to resubmit melanoma drug application
Brief: Bristol Myers Squibb Says Phase 3 Successor-2 Trial Shows MeziKd Achieves 18-Month Median PFS
Bristol Myers drug delays myeloma progression in hard to treat patients
China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says
Bristol Myers to deploy Anthropic's Claude AI model to speed up drug discovery
Brief: Bristol Myers Squibb Announces Strategic Agreement With Anthropic To Position Claude Enterprise As The Shared Intelligence Platform Across Its Global Operations
Brief: Bristol-Myers Squibb Brings Anthropic’s Claude To 30,000 Of Its Staff - WSJ
US Supreme Court rebuffs pharma challenge to Biden-era drug price
Brief: Mubadala Investment Dissolves Share Stake In Pfizer, Ford Motor, Walt Disney
US FDA approves BeOne's drug for a type of blood cancer (updated)
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees
Jiangsu Hengrui HK shares hit near 4-month peak on Bristol-Myers Squibb tie-up